Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Orrell

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Handbook of Clinical Neurology|April 19, 2011
Facioscapulohumeral dystrophy and scapuloperoneal syndromesRichard W Orrell
The New England Journal of Medicine|August 3, 2007
Understanding the causes of amyotrophic lateral sclerosisRichard W Orrell
Current Opinion in Investigational Drugs (London, England : 2000)|January 24, 2006
AEOL-10150 (Aeolus)Richard W Orrell
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2010
What is the clinical significance of SOD1 mutations in amyotrophic lateral sclerosis?Richard W Orrell
British Medical Bulletin|December 18, 2009
Motor neuron disease: systematic reviews of treatment for ALS and SMARichard W Orrell
Handbook of Clinical Neurology|September 24, 2008
Endocrine myopathiesRichard W Orrell
The Practitioner|October 29, 2011
GPs have key role in managing motor neurone diseaseRichard W Orrell
The Practitioner|November 9, 2017
Diagnosis and management of motor neurone diseaseRichard W Orrell
The Practitioner|December 21, 2012
Diagnosing and managing muscular dystrophyRichard W Orrell
British Medical Bulletin|July 25, 2016
Pathogenesis of amyotrophic lateral sclerosisSarah Morgan, Richard W Orrell
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Handbook of Clinical Neurology|April 19, 2011
Facioscapulohumeral dystrophy and scapuloperoneal syndromesRichard W Orrell
The New England Journal of Medicine|August 3, 2007
Understanding the causes of amyotrophic lateral sclerosisRichard W Orrell
Current Opinion in Investigational Drugs (London, England : 2000)|January 24, 2006
AEOL-10150 (Aeolus)Richard W Orrell
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2010
What is the clinical significance of SOD1 mutations in amyotrophic lateral sclerosis?Richard W Orrell
British Medical Bulletin|December 18, 2009
Motor neuron disease: systematic reviews of treatment for ALS and SMARichard W Orrell
Handbook of Clinical Neurology|September 24, 2008
Endocrine myopathiesRichard W Orrell
The Practitioner|October 29, 2011
GPs have key role in managing motor neurone diseaseRichard W Orrell
The Practitioner|November 9, 2017
Diagnosis and management of motor neurone diseaseRichard W Orrell
The Practitioner|December 21, 2012
Diagnosing and managing muscular dystrophyRichard W Orrell
British Medical Bulletin|July 25, 2016
Pathogenesis of amyotrophic lateral sclerosisSarah Morgan, Richard W Orrell
Pageof 7